VRTX
Vertex Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$109.34B
P/E Ratio
27.70
EPS
$15.52
Beta
0.30
52W High
$507.92
52W Low
$362.50
50-Day MA
$452.58
200-Day MA
$436.03
Dividend Yield
—
Profit Margin
32.90%
Forward P/E
22.32
PEG Ratio
2.08
About Vertex Pharmaceuticals Inc
Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts.
Fundamentals
| Revenue (TTM) | $12.00B |
| Gross Profit (TTM) | $6.44B |
| EBITDA | $4.87B |
| Operating Margin | 39.60% |
| Return on Equity | 22.50% |
| Return on Assets | 12.20% |
| Revenue/Share (TTM) | $46.94 |
| Book Value | $73.49 |
| Price-to-Book | 5.78 |
| Price-to-Sales (TTM) | 9.11 |
| EV/Revenue | 8.6 |
| EV/EBITDA | 21.22 |
| Quarterly Earnings Growth (YoY) | 32.90% |
| Quarterly Revenue Growth (YoY) | 9.50% |
| Shares Outstanding | $254.36M |
| Float | $253.24M |
| % Insiders | 0.21% |
| % Institutions | 97.18% |
Historical Volatility
HV 10-Day
16.41%
HV 20-Day
19.85%
HV 30-Day
23.57%
HV 60-Day
33.28%
HV Rank
32.9%
Volatility is currently contracting
Analyst Ratings
Consensus ($548.25 target)
5
Strong Buy22
Buy4
Hold1
Sell1
Strong SellMore HEALTHCARE Stocks
Data last updated: 5/5/2026